Skip to main content
. 2019 Mar 15;6(Suppl 1):S54–S62. doi: 10.1093/ofid/ofy344

Table 3.

Main Organisms and Organism Groups Stratified by Geography and Vancomycin Resistance Phenotype

Organism/Organism Group Asia-Pacific Europe Latin America North America Total
Enterococcus spp., No. (%) 3476 16 054 4755 25 206 49 491
 Vancomycin-susceptible (≤4 mg/L) 3135 (90.2) 14 626 (91.1) 4249 (89.4) 19 544 (77.5) 41 554 (84.0)
 Vancomycin-resistant (VanA) 232 (6.7) 1095 (6.8) 426 (9.0) 5035 (20.0) 6788 (13.7)
 Vancomycin-resistant (VanB) 89 (2.6) 279 (1.7) 44 (0.9) 415 (1.6) 827 (1.7)
Enterococcus faecium, No. (%) 1089 5229 876 7166 14 360
 Vancomycin-susceptible (≤4 mg/L) 780 (71.6) 3990 (76.3) 517 (59.1) 2268 (31.6) 7555 (52.6)
 Vancomycin-resistant (VanA) 227 (20.8) 992 (19.0) 323 (36.8) 4637 (64.7) 6179 (43.0)
 Vancomycin-resistant (VanB) 82 (7.5) 246 (4.7) 36 (4.1) 259 (3.6) 623 (4.3)
Enterococcus faecalis, No. (%) 2225 10 078 3524 16 188 32 015
 Vancomycin-susceptible (≤4 mg/L) 2213 (99.5) 9942 (98.6) 3413 (96.8) 15 631 (96.6) 31 199 (97.5)
 Vancomycin-resistant (VanA) 5 (0.2) 103 (1.0) 103 (3.0) 398 (2.5) 609 (1.9)
 Vancomycin-resistant (VanB) 7 (0.3) 33 (0.3) 8 (0.2) 156 (1.0) 204 (0.6)